Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Funding lifecycle and financial vocabulary

EIC selects 35 deep-tech firms for €84 million in proposed grants

The EIC selected 35 deep-tech companies for proposed grants totalling €84 million, with 32 facing separate equity assessments.

Published 17 Nov 2026· 5 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

The European Innovation Council selected 35 deep-tech companies for Accelerator support on 16 November 2026, proposing €84 million in grants across Europe and associated countries. For university spinouts and the research offices supporting them, the decision opens a route towards commercial development, with grant agreements still to be finalised and equity investment assessed separately.

What happened: 35 companies selected

The EIC announcement records 453 full applications and 88 companies reaching interviews. Of the 35 selected businesses, 32 will be assessed by the EIC Fund for investments of up to €10 million each. The €84 million figure covers proposed grants; it is separate from those potential equity investments.

ERA Portal Austria’s report says the cohort spans 17 EU and associated countries, with France, Switzerland and Germany accounting for the highest numbers of selected companies. Women hold key leadership positions, including chief executive, technology or scientific officer roles, at 31% of the businesses. That measure concerns these leadership roles collectively.

Key details of the funding decision

Measure Latest round
Full applications 453
Interview-stage applicants 88
Companies selected 35
Proposed grant funding €84 million
Companies facing equity assessment 32; up to €10 million each

These are the funder’s round-level figures. Selection and equity assessment are different stages of the financing process.

The technologies show the breadth of research commercialisation involved. The EIC identifies France’s DEESS, working on autonomous seabed-mapping robots; Poland’s Ecobean, developing modular coffee-waste biorefineries; and Switzerland’s Oxyle, using light to destroy PFAS. It also highlights Portugal’s Seamoretech, combining desalination with mineral recovery, and Latvia’s Sia Cellboxlab, developing microbiome-enabled organ-on-chip technology. Open Access Government’s coverage reports these environmental, industrial and biomedical applications.

Background: funding the move towards market

The EIC’s Accelerator programme page distinguishes grant support for innovation activities from investment for scaling up. Its application route starts with a short proposal, followed by a full proposal and a jury interview. Successful applicants then enter grant preparation and, where relevant, investment assessment. CASRAI’s guide to Accelerator grant and equity funding explains the financing model.

For institutions following the wider Horizon Europe funding system, this is a commercialisation decision with a company-level destination. The programme accepts SMEs established in EU Member States or associated countries, and has routes for people intending to establish eligible businesses. Its relevance to a university therefore depends on the company and the technology being developed.

The distinction between a research result and a business is visible in Planckian, one of the selected companies. Its own statement describes a 2023 spinout from the University of Pisa and Scuola Normale Superiore, based in Pisa and Milan. It develops superconducting quantum processors, offering a concrete example of the university spinout pathway.

Recipient reaction: Planckian’s route from lab to users

In its 16 November statement, Planckian describes a €2.5 million grant for a 24-month programme targeting a market-ready quantum computing system. It expects €7.5 million of EIC Fund equity alongside its upcoming Series A, subject to standard due diligence.

Co-founder and chief executive Michele Dallari said: “The EIC’s backing lets us take it from the lab to a system that external users can run.” The company says its architecture allows multiple qubits to share control lines, addressing the growth in wiring and associated costs as processors scale.

Quantum Zeitgeist’s report also links the selection to processor scaling and notes the due-diligence condition on the equity investment. The commercial system is the programme’s intended outcome; the announcement describes work still to be undertaken.

What it means for universities and research offices

For offices supporting selected spinouts, the immediate planning task is to track grant preparation separately from the investment process. A company’s proposed grant and prospective equity have different decision points. Treating both as cash already available would obscure the conditions described by the EIC and by Planckian.

For prospective applicants, the Accelerator page specifies full-proposal annexes covering financial data and the company’s capitalisation table, an intellectual-property strategy, and, for proposals requesting a grant, implementation milestones and a lump-sum budget. This gives technology-transfer and research-support teams a concrete preparation agenda: align the scientific development plan with ownership, IP and financial information before submission.

There is also a distinction for applicants outside the selected cohort. The EIC says 74 applications exceeding the evaluation threshold but lacking available funding will receive a Seal of Excellence; 13 companies meeting the Accelerator Challenges criteria will receive a STEP Seal. These recognitions are intended to help access complementary or alternative funding. Offices supporting those applicants can use the recognition in subsequent funding discussions.

What happens next

Grant agreements are expected within three months of the 16 November announcement, placing the anticipated preparation window into February 2027. Equity decisions remain with the EIC Fund, which works with private and public co-investors. Open Access Government also reports these separate next steps.

For the next applicant cohort, the EIC lists full-proposal batching dates of 20 January, 17 March, 1 September and 4 November 2027. Its 2027 funding-opportunities page also lists general information sessions on 19 November 2026 and Accelerator Challenges information on 20 November, giving research-support teams an immediate opportunity to prepare for the next cycle.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →